Genomic sequencing can transform the lives of people with epilepsy, giving insights into the cause, personalized medication, and risks of Sudden Unexpected Death in Epilepsy (SUDEP). Our world leading professors provide the scientific and medical expertise to make real breakthroughs possible.
It ran from 12:00 PM, 28 November 2017 to 12:00 PM, 5 December 2017
Registered Charity in England and Wales (206186)
Anyone can develop epilepsy, at any time of life. It happens in people of all ages, races and social classes. Epilepsy affects half million people in the UK, and every year 1000 people die from epilepsy, that’s eight people a day. Seizures and their treatment can be different for each person. There is no cure, and whilst some people can control their seizures through a cocktail of drugs the lives of others are severely impacted.
Genetics tell us more about a person’s epilepsy in a single test than any other source. We know we can transform the lives of many more people with epilepsy through groundbreaking whole genome sequencing. This will unlock the epilepsy DNA, let us develop personalized, more effective treatments, and reduce Sudden Unexpected Death in Epilepsy (SUDEP).
Please upgrade your browser to continue.